SABBY MANAGEMENT, LLC - 31 Dec 2024 SCHEDULE 13G Report for Scinai Immunotherapeutics Ltd. ADSs (BVXV)

Filing Manager
SABBY MANAGEMENT, LLC
Reporting Manager
SABBY MANAGEMENT, LLC
Security
Scinai Immunotherapeutics Ltd. ADSs
Symbol
BVXV
Shares outstanding
592,878 shares
Disclosed Ownership
29,051 shares
Ownership
4.9%
Form type
SCHEDULE 13G
Filing time
03 Jan 2025, 18:16:02 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
SABBY MANAGEMENT, LLC 4.9% 29,051 0 29,051 /S/ ROBERT GRUNDSTEIN COO
SABBY VOLATILITY WARRANT MASTER FUND LTD 4.9% 29,051 0 29,051 /S/ ROBERT GRUNDSTEIN COO OF INVESTMENT MANAGER
HAL MINTZ 4.9% 29,051 0 29,051 /S/ HAL MINTZ HAL MINTZ